Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 87/100 | DilutionWatch score record |
| Shares Outstanding | 92.98M | Verified float table or market cache |
| Public Float | 14.88M | Verified float table or market cache |
| Market Cap | $78.10M | Market data cache |
| Cash Runway | 10.7 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | 53.95M | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 3.
Recent SEC source mix: EFFECT 2, XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
CTOR SEC Filing Activity — Last 12 Months
Shares outstanding reported by CTOR on the cover page of its latest 10-K/10-Q: 92.98M as of August 13, 2026.
DilutionWatch recorded 7 registration or prospectus documents for CTOR (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| S-3 | shelf registration | 1 | Jan 05, 2026 |
| 424B5 | prospectus supplement (ATM / shelf takedown) | 1 | Dec 10, 2025 |
| 424B3 | prospectus (resale / ATM) | 4 | Jun 01, 2026 |
| POS AM | post-effective amendment to a registration statement | 1 | Feb 20, 2026 |
| EFFECT | SEC declared a registration effective | 3 | Jun 08, 2026 |
| 8-K | current report (material event) | 17 | Oct 26, 2026 |
| 10-Q | quarterly report | 1 | Aug 14, 2026 |
| DEF 14A | proxy statement | 1 | Aug 26, 2026 |
| SC 13G/A | amended passive >5% holder filing | 1 | Aug 14, 2026 |
| 3 | initial insider ownership | 3 | Aug 14, 2026 |
| 5 | annual insider ownership | 2 | Aug 26, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual CTOR Dilution Snapshot
Citius Oncology, Inc. (CTOR) has a DilutionScore of 87/100, rated Critical dilution risk. Score date: October 27, 2026.
- Stored outstanding warrants: 53.9M.
- Recent SEC activity tracked for CTOR: xbrl on 2026-08-14; EFFECT on 2026-03-02; EFFECT on 2026-01-12.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
CTOR's DilutionScore is currently 87/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 68/100 (High risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 13 – Oct 27, 2026 | 87/100 | CRITICAL | 15 days |
| Oct 01 – Oct 12, 2026 | 68/100 | HIGH | 12 days |
| Aug 22 – Sep 30, 2026 | 65/100 | HIGH | 40 days |
| Aug 14 – Aug 21, 2026 | 84/100 | CRITICAL | 7 days |
| Jul 30 – Aug 13, 2026 | 80/100 | CRITICAL | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.